Cargando…

Association of Advanced Glycation End Products With Lower-Extremity Atherosclerotic Disease in Type 2 Diabetes Mellitus

Aims: Advanced glycation end products (AGEs) were reported to be correlated with the development of diabetes, as well as diabetic vascular complications. Therefore, this study aimed at investigating the association between AGEs and lower-extremity atherosclerotic disease (LEAD). Methods: A total of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ying, Lingwen, Shen, Yun, Zhang, Yang, Wang, Yikun, Liu, Yong, Yin, Jun, Wang, Yufei, Yin, Jingrong, Zhu, Wei, Bao, Yuqian, Zhou, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460767/ https://www.ncbi.nlm.nih.gov/pubmed/34568445 http://dx.doi.org/10.3389/fcvm.2021.696156

Ejemplares similares

Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease
por: Shen, Yun, et al.
Publicado: (2020)

Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus
por: He, Xingxing, et al.
Publicado: (2017)

Serum 1,5-Anhydroglucitol to Glycated Albumin Ratio Can Help Early Distinguish Fulminant Type 1 Diabetes Mellitus from Newly Onset Type 1A Diabetes Mellitus
por: Ying, Lingwen, et al.
Publicado: (2020)

Glycation and a Spark of ALEs (Advanced Lipoxidation End Products) – Igniting RAGE/Diaphanous-1 and Cardiometabolic Disease
por: Arivazhagan, Lakshmi, et al.
Publicado: (2022)

Diverging effects of diabetes mellitus in patients with peripheral artery disease and abdominal aortic aneurysm and the role of advanced glycation end-products: ARTERY study — protocol for a multicentre cross-sectional study
por: de Vos, L C, et al.
Publicado: (2017)

Predictive value of 10-year atherosclerotic cardiovascular disease risk equations from the China-PAR for new-onset lower extremity peripheral artery disease
por: He, Pengkang, et al.
Publicado: (2022)

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
por: Bi, Lei, et al.
Publicado: (2022)

Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models
por: Egaña-Gorroño, Lander, et al.
Publicado: (2020)

Postload Glycated Albumin as an Alternate Measure for Diabetes Screening in a Chinese Population
por: Su, Hang, et al.
Publicado: (2018)

Classic Type 1 Diabetes Mellitus and Fulminant Type 1 Diabetes Mellitus: Similarity and Discrepancy of Immunological Characteristics and Cytokine Profile
por: Ying, Lingwen, et al.
Publicado: (2021)

Advanced Glycation End Products as a Predictor of Diabetes Mellitus in Chronic Hepatitis C-Related Cirrhosis
por: Abdel-Razik, Ahmed, et al.
Publicado: (2020)

Advanced Glycation End Products in the Skin: Molecular Mechanisms, Methods of Measurement, and Inhibitory Pathways
por: Chen, Chun-yu, et al.
Publicado: (2022)

Effects of the different Tai Chi exercise cycles on patients with essential hypertension: A systematic review and meta-analysis
por: Yin, Yikun, et al.
Publicado: (2023)

The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus
por: Xu, Shuai, et al.
Publicado: (2022)

Antithrombotic Treatment in Lower Extremity Peripheral Arterial Disease
por: Gottsäter, Anders
Publicado: (2021)

Coronary Atherosclerotic Disease and Cancer: Risk Factors and Interrelation
por: Li, Jinjing, et al.
Publicado: (2022)

Plasma Testosterone Levels and Atherosclerotic Plaque Gene Expression in Men With Advanced Atherosclerosis
por: Groepenhoff, Floor, et al.
Publicado: (2021)

Comparative Agreement Analysis of Differences in 1,5-Anhydroglucitol, Glycated Albumin, and Glycated Hemoglobin A1c Levels between Fasting and Postprandial States in Steamed Bread Meal Test
por: Su, Hang, et al.
Publicado: (2017)

Effects of Enhanced External Counterpulsation With Different Sequential Levels on Lower Extremity Hemodynamics
por: Zhang, Yahui, et al.
Publicado: (2021)

Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques
por: Pinto, Raphael S, et al.
Publicado: (2022)

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
por: Wang, Kexin, et al.
Publicado: (2022)

Effects of norepinephrine on plaque hypoxia in atherosclerotic rabbits
por: Wang, Jia-Yu, et al.
Publicado: (2023)

The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes
por: He, Xingxing, et al.
Publicado: (2020)

Efficacy and safety evaluation of rivaroxaban vs. warfarin among non-valvular atrial fibrillation patients undergoing lower extremity revascularization
por: Yu, Qingyuan, et al.
Publicado: (2022)

Advanced-Glycation End-Products Induce Podocyte Injury and Contribute to Proteinuria
por: Nishad, Rajkishor, et al.
Publicado: (2021)

The relationship between Type D personality with atherosclerotic plaque and cardiovascular events: The mediation effect of inflammation and kynurenine/tryptophan metabolism
por: Wang, Yini, et al.
Publicado: (2022)

Interleukin-17-Producing CD4(+) T Cells Promote Inflammatory Response and Foster Disease Progression in Hyperlipidemic Patients and Atherosclerotic Mice
por: Wang, Yin, et al.
Publicado: (2021)

Combination of Exercise Testing Criteria to Diagnose Lower Extremity Peripheral Artery Disease
por: Stivalet, Olivier, et al.
Publicado: (2021)

Inflammatory Mediators in Atherosclerotic Vascular Remodeling
por: Evans, Bryce R., et al.
Publicado: (2022)

Low-iodine 40-keV virtual monoenergetic CT angiography of the lower extremities
por: Fahrni, Guillaume, et al.
Publicado: (2023)

Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, China
por: Liu, Hui, et al.
Publicado: (2023)

Advances in Cardiotoxicity Induced by Altered Mitochondrial Dynamics and Mitophagy
por: Yin, Yiyuan, et al.
Publicado: (2021)

Renal perfusion improvement in the perioperative period after unilateral endovascular revascularization in patients with atherosclerotic renal artery stenosis
por: Xu, Leyin, et al.
Publicado: (2023)

Novel Insight Into Long-Term Risk of Major Adverse Cardiovascular and Cerebrovascular Events Following Lower Extremity Arteriosclerosis Obliterans
por: Sun, Ji, et al.
Publicado: (2022)

Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque
por: Wang, Xueyu, et al.
Publicado: (2021)

Defective Protein Catabolism in Atherosclerotic Vascular Inflammation
por: Miyazaki, Takuro, et al.
Publicado: (2017)

Artificial intelligence in atherosclerotic disease: Applications and trends
por: Kampaktsis, Polydoros N., et al.
Publicado: (2023)

Are acute type A aortic dissections atherosclerotic?
por: Grewal, Nimrat, et al.
Publicado: (2023)

The relationships between cholesterol crystals, NLRP3 inflammasome, and coronary atherosclerotic plaque vulnerability in acute coronary syndrome: An optical coherence tomography study
por: Xue, Chao, et al.
Publicado: (2022)

Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
por: Khalid, Mariyam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_23j6eh8eto7n1kssk38k02s6q6